DOHA: Sidra Medicine, a member of Qatar Foundation, has launched a state-of-the-art cord blood banking service. This is the country's first local cord blood storage facility and will offer families a unique opportunity to preserve their newborns' stem cells in Qatar, for potential future medical needs.
Cord blood banking is the process of collecting and storing the blood from a newborn's umbilical cord and placenta after birth. The collection is painless, non-invasive, and risk-free for the mother and baby. Cord blood is rich in hematopoietic stem cells, which have the potential to treat various medical conditions, including certain cancers, blood disorders, and immune system diseases.
Prof. Johnny Awwad, Chair of Women's Services at Sidra Medicine said: "As the only facility in Qatar providing local cord blood storage, Sidra Medicine offers an unparalleled advantage by keeping the samples in the country. This ensures their optimal quality and immediate access when needed most, compared to having them shipped from abroad. Cord blood is increasingly being stored by parents everywhere, who are seeking to preserve their child's stem cells as they can be crucial for their child or their sibling/s in the future. Our commitment to the latest technology and international standards further guarantees the utmost reliability and peace of mind for families in Qatar." All the cord blood samples will be sent to Sidra Medicine's Cord Blood Bank in its Good Manufacturing Practice (GMP) facility, where cryogenic freezing will allow them to be stored securely for over 30 years.
Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine said: "Our cord blood banking service is another successful milestone for our precision medicine strategy. There are over 80 diseases that can be treated using the banked samples including some types of cancers. With this private service now available for maternity patients at Sidra Medicine, we provide parents with the opportunity to safeguard their child's future health by cryopreserving their stem cells. This is particularly relevant for families with a history of congenital medical issues. The stored stem cells could provide a source for regenerative therapies if their child or other family members experience blood or immune system disorders." To expand its reach to other families in Qatar, Sidra Medicine signed a Memorandum of Understanding with CellSave Arabia, a leader in stem cell banking services. It is available to any family in the country choosing the joint Sidra Medicine and CellSave Arabia service as their stem cell storage provider regardless of whichever hospital their baby is born in.
Dr. Iyabo Tinubu-Karch, Chief Executive Officer of Sidra Medicine said: "This partnership with CellSave Arabia aligns perfectly with Sidra Medicine's mission to advance healthcare and foster healthier families across Qatar. Thanks to our facilities and CellSave Arabia's reach, this is the first time that families across the country have an option to have their children's stem cells stored in the country. Together, we aim to make advanced stem cell processing and storage more accessible, thereby contributing to a more robust healthcare infrastructure in the region."
Cord blood banking is already available at Sidra Medicine and plans are underway to extend the joint Sidra Medicine and CellSave Arabia service to those who deliver their babies in other hospitals in addition to launching other services including umbilical cord banking, placental tissue banking, amniotic tissue banking, and Mesenchymal Stem Cell (MSC) banking.